
- ONCOLOGY Vol 12 No 11
 - Volume 12
 - Issue 11
 
University of Minnesota Cancer Center Achieves ‘Comprehensive’ Status
The University of Minnesota Cancer Center has been designated a "comprehensive cancer center" by the National Cancer Institute. To quality for the title "comprehensive," a center must conduct basic and clinical research, as well as prevention, control, and population studies; exhibit a strong body of interactive research bridging these key areas; and have outreach, education, and information programs in place. Only 35 of the 58 NCI-designated cancer centers meet the requirements for the "comprehensive" designation.
The University of Minnesota Cancer Center has been designated a "comprehensive cancer center" by the National Cancer Institute. To quality for the title "comprehensive," a center must conduct basic and clinical research, as well as prevention, control, and population studies; exhibit a strong body of interactive research bridging these key areas; and have outreach, education, and information programs in place. Only 35 of the 58 NCI-designated cancer centers meet the requirements for the "comprehensive" designation.
"Were extremely pleased that the National Cancer Institute and our national peers have recognized the breadth of our cancer research program as well as our efforts to serve the community," said John H. Kersey, MD, director of the University of Minnesota Cancer Center. The University of Minnesota Cancer Center is the only NCI-designated comprehensive cancer center in the state of Minnesota
Articles in this issue
about 27 years ago
Phase III Results of Second-Generation HIV Protease Inhibitor Reportedabout 27 years ago
Telomerase Rejuvenates Cells Without Causing Malignant Transformationabout 27 years ago
Hoechst Marion Roussel Launches Antiemetic Information Centerabout 27 years ago
Telomerase Rejuvenates Cells Without Causing Malignant Transformationabout 27 years ago
Intraoperative Ultrasound-Guided Cryoablation of Renal Tumorsabout 27 years ago
First Doris Duke Clinical Scientist Awards Announcedabout 27 years ago
Phase III Results of Second-Generation HIV Protease Inhibitor ReportedNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



















































































